Clinical Trials Directory

Trials / Completed

CompletedNCT03587415

Serum Preptin and Amylin Levels in Polycystic Ovary Syndrome Patients

Serum Preptin and Amylin Levels With Respect to Body Mass Index in Polycystic Ovary

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Recep Tayyip Erdogan University Training and Research Hospital · Academic / Other
Sex
Female
Age
17 Years – 35 Years
Healthy volunteers
Accepted

Summary

Preptin and amylin are pancreatic hormones which participate in glucose homeostasis. This study aims to evaluate how serum preptin and amylin levels are altered in polycystic ovary syndrome (PCOS) patients and healthy women based on BMI groups .

Detailed description

Materials and Methods: This is a cross-sectional review of 40 PCOS patients and 40 healthy women who were matched with respect to BMI (\<25 kg/m2 and ≥25 kg/m2).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTpreptin and amylin levelwe will take both of group blood samples to compare them serum preptin and amylin

Timeline

Start date
2017-06-28
Primary completion
2017-11-30
Completion
2017-12-07
First posted
2018-07-16
Last updated
2018-07-16

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03587415. Inclusion in this directory is not an endorsement.